Patents by Inventor Theodorus Jansen

Theodorus Jansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11065324
    Abstract: The present invention relates to a combination vaccine for swine, comprising non-replicating antigen from porcine circovirus type 2 (PCV2), and live porcine reproductive and respiratory syndrome virus (PRRSV); the combination vaccine is formulated as an oil-in-water emulsion, and is adjuvated with squalane and vitamin E-acetate. This combination vaccine was found to be immunologically effective against all pathogens: PCV2, and PRRSV.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: July 20, 2021
    Assignee: Intervet, Inc.
    Inventors: Theodorus Jansen, Maarten Hendrik Witvliet
  • Publication number: 20200329736
    Abstract: An extrusion process is disclosed for turning vegetable protein compositions such as soy protein into a fibrous, meat-like structure. The process involves the application of relatively high moisture contents. An open structure is produced that can be infused with water so as to influence the product's tenderness. The products of the invention can be provided with a fibrosity and tenderness at will. The invention offers the possibility to include relatively high amounts of fat in the product.
    Type: Application
    Filed: June 26, 2020
    Publication date: October 22, 2020
    Inventors: Franciscus Egenius Giezen, Wouter Wilhelmus Johannes Theodorus Jansen, Jeroen Harold Anton Willemsen
  • Patent number: 10716319
    Abstract: An extrusion process is disclosed for turning vegetable protein compositions such as soy protein into a fibrous, meat-like structure. The process involves the application of relatively high moisture contents. An open structure is produced that can be infused with water so as to influence the product's tenderness. The products of the invention can be provide with a fibrosity and tenderness at will. The invention offers the possibility to include relatively high amounts of fat in the product.
    Type: Grant
    Filed: May 10, 2012
    Date of Patent: July 21, 2020
    Assignee: Ojah B.V.
    Inventors: Franciscus Egenius Giezen, Wouter Wilhelmus Johannes Theodorus Jansen, Jeroen Harold Anton Willemsen
  • Publication number: 20200085935
    Abstract: The present invention relates to a combination vaccine for swine, comprising non-replicating antigen from porcine circovirus type 2 (PCV2), and live porcine reproductive and respiratory syndrome virus (PRRSV); the combination vaccine is formulated as an oil-in-water emulsion, and is adjuvated with squalane and vitamin E-acetate. This combination vaccine was found to be immunologically effective against all pathogens: PCV2, and PRRSV.
    Type: Application
    Filed: December 22, 2017
    Publication date: March 19, 2020
    Applicant: Intervet Inc.
    Inventors: Theodorus Jansen, Maarten Hendrik Witvliet
  • Patent number: 10568954
    Abstract: The present invention describes a process for the preparation of an antigen composition, which antigen composition can be used to prepare a ready-to-use vaccine for swine, for preventing or reducing infection by M. hyo or PCV2 and associated signs of disease. The process is characterised in that it comprises a step of admixing a PCV2 antigen to a pre-formed antigen/adjuvant complex of an M. hyo antigen adsorbed to an Aluminium-hydroxide adjuvant. This way a PCV2/M. hyo combination vaccine can be prepared that is highly effective already after a single administration, against infection and disease by M. hyo and PCV2 either when in single or in combined infections. Also the vaccine has very good safety upon administration, is ready-to-use, and is economically feasible.
    Type: Grant
    Filed: December 10, 2015
    Date of Patent: February 25, 2020
    Assignee: Intervet Inc.
    Inventors: Maarten Hendrik Witvliet, Theodorus Jansen, Huchappa Gowda Jayappa
  • Publication number: 20190175116
    Abstract: The present invention relates to a sensor device (100, 101, 102, 103) for sensing physiological information of a subject. To efficiently avoid or reduce ambient interference, the sensor device comprises a communication unit (7) for receiving, from an external source, context information indicating one or more of a modulation mode, settings of an interference reduction algorithm, and spectral information indicating an ambient light spectrum, said spectral information allowing the sensor device to determine the modulation mode and/or settings of an interference reduction algorithm, one or more light emitters (1, 2) for emitting modulated light onto the tissue of the subject, and a light detector (4) for detecting light which is transmitted through the tissue or/and which is reflected from the tissue.
    Type: Application
    Filed: August 7, 2017
    Publication date: June 13, 2019
    Inventors: Ralph WIJSHOFF, Theodorus JANSEN, Anthonius JANSSEN, Joseph FALLON
  • Publication number: 20170340723
    Abstract: The present invention describes a process for the preparation of an antigen composition, which antigen composition can be used to prepare a ready-to-use vaccine for swine, for preventing or reducing infection by M. hyo or PCV2 and associated signs of disease. The process is characterised in that it comprises a step of admixing a PCV2 antigen to a pre-formed antigen/adjuvant complex of an M. hyo antigen adsorbed to an Aluminium-hydroxide adjuvant. This way a PCV2/M. hyo combination vaccine can be prepared that is highly effective already after a single administration, against infection and disease by M. hyo and PCV2 either when in single or in combined infections. Also the vaccine has very good safety upon administration, is ready-to-use, and is economically feasible.
    Type: Application
    Filed: December 10, 2015
    Publication date: November 30, 2017
    Applicant: Intervet Inc.
    Inventors: Maarten Hendrik WITVLIET, Theodorus JANSEN, Huchappa Gowda JAYAPPA
  • Patent number: 9579369
    Abstract: The present invention generally relates to the fields of parasitology and immunology, and especially to a vaccine against Rhipicephalus ticks. In particular the invention relates to a composition comprising a first and a second protein, in particular Bm86 and Subolesin proteins, including their homologs or immunogenic fragments; to the use of such a composition as a vaccine against Rhipicephalus ticks, and to the use of the first and the second isolated proteins for the vaccination of a target against Rhipicephalus ticks.
    Type: Grant
    Filed: March 28, 2014
    Date of Patent: February 28, 2017
    Assignee: Intervet Inc.
    Inventors: Theodorus Petrus Maria Schetters, Theodorus Jansen
  • Patent number: 9492548
    Abstract: The present invention pertains to an emulsion comprising an aqueous phase and an oily phase, the aqueous phase containing a non-live medicinal substance, wherein the aqueous phase comprises at least 30% w/w sugar. The invention also pertains to a method to shield a medicinal substance present in an aqueous phase emulsified with an oily phase, from interaction with the oily phase, and to a vaccine comprising as an antigen a killed micro-organism or a subunit of a micro-organism, the antigen being present in an aqueous phase that is dispersed in an oily phase, wherein the aqueous phase comprises at least 30% w/w sugar.
    Type: Grant
    Filed: December 11, 2013
    Date of Patent: November 15, 2016
    Assignee: Intervet Inc.
    Inventors: Erwin Mombarg, Theodorus Jansen, Henricus Johannes Maria Jagt
  • Patent number: 9408804
    Abstract: The present invention pertains to a method for keeping an immunogenic composition available for administration to an animal, wherein said composition comprises an antigen and an emulsion which is a single emulsion at a first temperature below a body temperature of the animal and which emulsion reverses at a second temperature between the first temperature and the body temperature, said method comprising providing the composition, freezing the composition, and storing the frozen composition until it is needed for administration to the animal. The invention also pertains to a method for testing an immunogenic composition, and an immunogenic composition, optionally in combination with specific instructions for storing the composition.
    Type: Grant
    Filed: May 18, 2010
    Date of Patent: August 9, 2016
    Assignee: Intervet Inc.
    Inventors: Nicolaas Visser, Theodorus Jansen
  • Publication number: 20160051649
    Abstract: The present invention generally relates to the fields of parasitology and immunology, and especially to a vaccine against Rhipicephalus ticks. In particular the invention relates to a composition comprising a first and a second protein, in particular Bm86 and Subolesin proteins, including their homologs or immunogenic fragments; to the use of such a composition as a vaccine against Rhipicephalus ticks, and to the use of the first and the second isolated proteins for the vaccination of a target against Rhipicephalus ticks.
    Type: Application
    Filed: March 28, 2014
    Publication date: February 25, 2016
    Applicant: INTERVET INC.
    Inventors: Theodorus Petrus Maria Schetters, Theodorus Jansen
  • Publication number: 20140271713
    Abstract: The present invention pertains to a method for keeping a foot-and-mouth disease vaccine available for emergency vaccination of animals against foot-and-mouth disease, the vaccine comprising a foot-and-mouth disease antigen formulated in a water-in-oil emulsion, the method comprising the steps of providing the formulated vaccine, freezing the vaccine, and storing the frozen vaccine until it is needed for emergency vaccination.
    Type: Application
    Filed: May 28, 2014
    Publication date: September 18, 2014
    Inventors: Daniel G.E. Goovaerts, Theodorus Jansen, Guntram Paul
  • Publication number: 20140170185
    Abstract: The present invention pertains to an emulsion comprising an aqueous phase and an oily phase, the aqueous phase containing a non-live medicinal substance, wherein the aqueous phase comprises at least 30% w/w sugar. The invention also pertains to a method to shield a medicinal substance present in an aqueous phase emulsified with an oily phase, from interaction with the oily phase, and to a vaccine comprising as an antigen a killed micro-organism or a subunit of a micro-organism, the antigen being present in an aqueous phase that is dispersed in an oily phase, wherein the aqueous phase comprises at least 30% w/w sugar.
    Type: Application
    Filed: December 11, 2013
    Publication date: June 19, 2014
    Inventors: Erwin MOMBARG, Theodorus JANSEN, Henricus Johannes Maria JAGT
  • Publication number: 20140149243
    Abstract: System for software vendor integration into an electronic marketplace. An example system receives, via an electronic software marketplace and from a user who is signed in to the electronic software marketplace, a request to download a software application hosted by a software vendor. The example system populates a form request for the software application with information from a user profile associated with the user, and submits the form request to the software vendor such that the user can download the software application directly from the software vendor.
    Type: Application
    Filed: November 29, 2012
    Publication date: May 29, 2014
    Applicant: RED HAT, INC.
    Inventor: Gerardus Theodorus Jansen
  • Publication number: 20140127363
    Abstract: An extrusion process is disclosed for turning vegetable protein compositions such as soy protein into a fibrous, meat-like structure. The process involves the application of relatively high moisture contents. An open structure is produced that can be infused with water so as to influence the product's tenderness. The products of the invention can be provide with a fibrosity and tenderness at will. The invention offers the possibility to include relatively high amounts of fat in the product.
    Type: Application
    Filed: May 10, 2012
    Publication date: May 8, 2014
    Applicant: Ojah B.V.
    Inventors: Franciscus Egenius Giezen, Wouter Wilhelmus Johannes Theodorus Jansen, Jeroen Harold Anton Willemsen
  • Patent number: 8496939
    Abstract: Personal care or cosmetic oil in water emulsions include an oil emulsifier and a combination of a Xanthan polysaccharide and a polyglucomannan polysaccharide to provide enhanced stability even at low emulsifier stabilizer levels. The emulsifier stabilizer system provides stable emulsions without dominating system rheology, particularly viscosity. Thus, the emulsions can have a low viscosity suitable for formulation as milks or thin lotions, or can be thickened, desirably by thickening agents other than the Xanthans and/or polyglucomannan, to provide emulsion creams or gels. This enables the system to be used very flexibly in end use applications. The emulsifier is desirably a non-ionic emulsifier and particularly is a combination of a low HLB and a high HLB emulsifier and can be formulated with conventional alcohol ethoxylate surfactants or from non-EO surfactants e.g. sucrose ester high HLB surfactants and citrate or sorbitan ester low HLB surfactants.
    Type: Grant
    Filed: February 26, 2002
    Date of Patent: July 30, 2013
    Assignee: Intervet International B.V.
    Inventors: Theodorus Jansen, Virgil Elisabeth Joseph Caspar Schijns, Erik Hermkens
  • Publication number: 20120087945
    Abstract: The present invention pertains to a method for keeping an immunogenic composition available for administration to an animal, wherein said composition comprises an antigen and an emulsion which is a single emulsion at a first temperature below a body temperature of the animal and which emulsion reverses at a second temperature between the first temperature and the body temperature, said method comprising providing the composition, freezing the composition, and storing the frozen composition until it is needed for administration to the animal. The invention also pertains to a method for testing an immunogenic composition, and an immunogenic composition, optionally in combination with specific instructions for storing the composition.
    Type: Application
    Filed: May 18, 2010
    Publication date: April 12, 2012
    Inventors: Nicolaas Visser, Theodorus Jansen
  • Publication number: 20120070459
    Abstract: The present invention pertains to a method for keeping a foot-and-mouth disease vaccine available for emergency vaccination of animals against foot-and-mouth disease, the vaccine comprising a foot-and-mouth disease antigen formulated in a water-in-oil emulsion, the method comprising the steps of providing the formulated vaccine, freezing the vaccine, and storing the frozen vaccine until it is needed for emergency vaccination.
    Type: Application
    Filed: September 24, 2010
    Publication date: March 22, 2012
    Inventors: Daniel G.E. Goovaerts, Theodorus Jansen, Guntram Paul
  • Patent number: 8073972
    Abstract: A system and method for enabling a client to query a DNS server for location information that is associated with the client's IP address. The client receives the location information which identifies a list of sub-locations and a location IP address space encompassing the sub-locations listed. The client selects a network service located nearest to the client based on the location information, and then accesses the network service.
    Type: Grant
    Filed: May 26, 2009
    Date of Patent: December 6, 2011
    Assignee: Red Hat, Inc.
    Inventors: Gerardus Theodorus Jansen, Simo S. Sorce
  • Publication number: 20040071716
    Abstract: The present invention provides adjuvants, for use in vaccine formulation, comprising a water-in-oil emulsion, characterised in that said emulsion comprises a polymeric emulsifier which is a block copolymer having a general formula A-COO-B-OOC-A, in which B is the divalent residue of a water-soluble polyalkylene glycol and A is the residue of a oil-soluble complex mono-carboxylic acid. Such polymeric emulsifier, as well as the preparation thereof, has been disclosed in GB 2002400 and WO9607689. Preferably in the blockcopolymers of formula A-COO-B-OOC-A, component B is derived from polyethylene glycol and components A are derived from polyhydroxystearic acid, preferably from poly(12-hydroxy-stearic acid). Most preferred emulsifiers used in the adjuvants according to the invention are Arlacel P135, a PEG 30 Dipolyhydroxystearate. Another, similar, emulsifier for use with the invention is ATLOX® 4912.
    Type: Application
    Filed: August 28, 2003
    Publication date: April 15, 2004
    Inventors: Theodorus Jansen, Virgil Elisabeth Joseph Caspar Schijns, Erik Hermkens